siRNA treatment reduces triglycerides in people along with uncommon disorder

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride levels through 80% and also reduced the danger of pancreatitis in patients along with relentless chylomicronemia, with or even without a genetic diagnosis.